Catalyst Biosciences, Inc. (CBIO): Price and Financial Metrics

Catalyst Biosciences, Inc. (CBIO)

Today's Latest Price: $5.37 USD

0.23 (-4.11%)

Updated Oct 28 10:10am

Add CBIO to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 384 in Biotech

See all "A" rated Strong Buy stocks

CBIO Stock Summary

  • For CBIO, its debt to operating expenses ratio is greater than that reported by only 5.81% of US equities we're observing.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.19 for Catalyst Biosciences Inc; that's greater than it is for just 11.35% of US stocks.
  • Catalyst Biosciences Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -47.97%, greater than the shareholder yield of just 8.66% of stocks in our set.
  • Stocks that are quantitatively similar to CBIO, based on their financial statements, market capitalization, and price volatility, are ETTX, ACIU, CDTX, SYBX, and LOGC.
  • Visit CBIO's SEC page to see the company's official filings. To visit the company's web site, go to

CBIO Stock Price Chart Interactive Chart >

Price chart for CBIO

CBIO Price/Volume Stats

Current price $5.37 52-week high $8.94
Prev. close $5.60 52-week low $3.43
Day low $5.21 Volume 52,407
Day high $5.42 Avg. volume 281,126
50-day MA $4.91 Dividend yield N/A
200-day MA $5.75 Market Cap 118.48M

Catalyst Biosciences, Inc. (CBIO) Company Bio

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on engineering proteases as therapeutics for hemophilia, hemeostasis, complement-mediated diseases, and other unmet medical needs. The company is based in South San Francisco, California.

CBIO Latest News Stream

Event/Time News Detail
Loading, please wait...

CBIO Latest Social Stream

Loading social stream, please wait...

View Full CBIO Social Stream

Latest CBIO News From Around the Web

Below are the latest news stories about Catalyst Biosciences Inc that investors may wish to consider to help them evaluate CBIO as an investment opportunity.

Catalyst Biosciences (CBIO) Presents At Morgan Stanley Global Healthcare Conference - Slideshow

The following slide deck was published by Catalyst Biosciences, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | September 18, 2020

Catalyst Biosciences Presents Data at the International Society for Thrombosis and Haemostasis (ISTH) Virtual Congress

Subcutaneous marzeptacog alfa (activated) (MarzAA) rapidly achieves and maintains therapeutic levels Data confirm Phase 3 study design to treat acute bleeding events in.

Yahoo | July 13, 2020

Does Catalyst Biosciences' (NASDAQ:CBIO) Share Price Gain of 34% Match Its Business Performance?

It might be of some concern to shareholders to see the Catalyst Biosciences, Inc. (NASDAQ:CBIO) share price down 24...

Yahoo | July 9, 2020

Hedge Funds Still Very Bullish On Catalyst Biosciences Inc (CBIO)

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find articles about an individual hedge fund's trades on numerous financial […]

Yahoo | July 8, 2020

Catalyst Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

The stock option was granted as an inducement material to Mr. Musil’s entering into employment with Catalyst in accordance with Nasdaq Listing Rule 5635(c)(4). The stock option was granted outside of Catalyst’s 2018 Omnibus Incentive Plan, but except as set forth in the stock option agreement, will generally be subject to the same terms and conditions as apply to stock options granted under the plan.

Yahoo | July 1, 2020

Read More 'CBIO' Stories Here

CBIO Price Returns

1-mo 22.60%
3-mo 0.56%
6-mo -4.79%
1-year -4.62%
3-year 14.50%
5-year -90.73%
YTD -21.15%
2019 -13.69%
2018 -42.16%
2017 39.90%
2016 -79.23%
2015 -77.10%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7488 seconds.